Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
28.06
+0.24 (0.86%)
Mar 9, 2026, 1:57 PM EDT - Market open
Edgewise Therapeutics Employees
Edgewise Therapeutics had 146 employees as of December 31, 2025. The number of employees increased by 36 or 32.73% compared to the previous year.
Employees
146
Change (1Y)
36
Growth (1Y)
32.73%
Revenue / Employee
n/a
Profits / Employee
-$1,149,281
Market Cap
3.01B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Arcus Biosciences | 601 |
| Denali Therapeutics | 503 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Vera Therapeutics | 224 |
| Alumis | 223 |
| Catalyst Pharmaceuticals | 182 |
| IDEAYA Biosciences | 145 |
EWTX News
- 5 days ago - Edgewise Therapeutics to Present at the Leerink Global Healthcare Conference on March 11, 2026 - PRNewsWire
- 6 days ago - Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2026 MDA Clinical and Scientific Conference - PRNewsWire
- 7 days ago - Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - PRNewsWire
- 11 days ago - Edgewise Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results with Strong Progress Across Muscular Dystrophy and Cardiovascular Programs - PRNewsWire
- 4 weeks ago - Edgewise Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026 - PRNewsWire
- 7 weeks ago - Edgewise Therapeutics, Inc. (EWTX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026 - PRNewsWire
- 2 months ago - Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 - PRNewsWire